Skip to main content
Equibles
JBIO logo

JBIO · Jade Biosciences, Inc. · Share Buybacks

Track JBIO — free

Use JBIO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research JBIO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$14.07 -0.05 (-0.35%) At close · Oct 5
Russell 2000 member Rebalance outlook locked
Going-concern doubt — flagged Aug 10, 2026

Substantial doubt about the company's ability to continue as a going concern.

“If we are unable to raise additional capital when needed, that could raise substantial doubt about our ability to continue as a going concern.”
View the 10-Q filed Aug 10, 2026
Market Cap
$917.07M
Shares
63.60M
Volume · Oct 5 607.06K Avg daily vol (3M) 898.64K

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Remaining Authorization
1,133,122 shares
as of 2026-06-30

Equity Offering (ATM) Programs

Program Established Capacity Remaining Runs Through
2026-05-07 $200,000,000 — —
Key facts CIK 1798749 CUSIP 008064206 13F (30d) 2 filings 2 filers Visit website Investor relations